Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
VYVGART could be the first CIDP drug with a novel mechanism in 30 years
Cambridge firm in-licenses two oncology programmes
Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex […]
A new study uses AI to modify drug doses for personalized cancer treatment.
MHRA authorises drug for adults with rare heart muscle damage